• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    92.50 Down 6.44(6.51%) Feb 5, 4:00PM EST
    |After Hours : 92.48 Down 0.02 (0.02%) Feb 5, 5:25PM EST
    Prev Close:98.94
    Open:98.70
    Bid:45.22 x 1400
    Ask:94.45 x 400
    1y Target Est:122.50
    Beta:0.908519
    Next Earnings Date:10-Feb-16LGND Earnings announcement
    Day's Range:92.06 - 100.50
    52wk Range:49.65 - 114.00
    Volume:545,351
    Avg Vol (3m):382,118
    Market Cap:1.84B
    P/E (ttm):7.61
    EPS (ttm):12.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDDown 6.51%1.84B
    MRKUp 1.63%137.95B
    LLYUp 0.05%78.70B

    Key Statistics

    Forward P/E (1 yr):27.13
    P/S (ttm):26.74
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :3.36
    Quarterly EPS Est (Dec-15) :0.65
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):0.63

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback